Question 1

Do AI shelf simulations complement or compete with packaging mock-up tests?

Accepted Answer

AI-driven shelf simulations are best used as a complement to physical packaging mock-up tests, not an outright replacement. Virtual shelf tests (using VR or AI to model store shelves) let you experiment quickly and cheaply with package designs and placements, identifying promising options early. They can generate heatmaps of what catches the eye or simulate how a new box would look among competitors. However, these simulations can't replicate everything - factors like package texture, real lighting, and shoppers' tactile interaction only come out in a physical mock-up test. So the smart approach is to use simulations to narrow down concepts or flag obvious issues, then confirm those findings with in-person shelf tests. This way, you benefit from both speed and realism, balancing innovation with validation.

Question 2

How can I prove ROI from in-store merchandising research?

Accepted Answer

To prove return on investment (ROI) from in-store merchandising research, link the insights to tangible improvements in sales or efficiency and quantify the before-and-after impact. For example, if the research suggested a new shelf layout and you implemented it in select stores, track the sales lift or basket size increase in those test stores versus control stores that kept the old layout; a significant uptick in revenue, after accounting for costs, directly demonstrates ROI. If sales data isn't straightforward, look at related metrics like improved product visibility (measured by shopper observations) leading to higher conversion rates, or time saved by staff due to a better stocking system. The key is isolating the effect of the merchandising changes: use a control vs. experimental setup or compare pre- and post-change figures while keeping other factors constant (no big promos skewing the results). By translating the research outcomes into dollar figures — like a percentage sales increase or cost saving attributed to the new display — stakeholders can clearly see that the study paid off and was worth the investment.

Question 3

Can AI models predict trial outcomes or patient adherence reliably?

Accepted Answer

AI models show promise in predicting clinical trial outcomes or patient adherence, but they aren't yet reliably accurate on their own. Machine learning algorithms can crunch historical trial data and electronic health records to spot patterns - like which patient profiles are more likely to drop out or which treatment arms might succeed. These predictions can help researchers allocate resources or identify risks early (for example, flagging patients who might need extra support to stick with a regimen). However, human biology and behavior are complex: an AI might overfit to past data or miss a new causal factor, leading to false confidence. Teams treat these model outputs as decision support rather than gospel. In practice, companies use AI insights to enhance planning and monitoring, but still rely on clinical expertise and real-world trial data to make final calls.

Question 4

How can I demonstrate ROI from path-to-purchase studies to retail partners?

Accepted Answer

To show return on investment (ROI) from a path-to-purchase study to your retail partners, link the study's insights to specific, measurable improvements in their stores or sales metrics. Start by implementing one or two key recommendations from the research in a pilot (for instance, changing a product placement or tweaking an in-store promotion based on the study's findings) at a subset of stores or for a certain period. Then track the results: did those stores see a lift in conversion rates, higher basket sizes, or faster customer throughput compared to stores that didn't make the change? If the data shows a clear uptick - say a 10% sales increase in a category after re-merchandising according to the study - you can confidently attribute that gain to the research and calculate the dollar impact. Presenting that kind of before-and-after evidence (ideally as a simple case study) makes a compelling argument to retail partners: it demonstrates that insights from the study drove tangible benefits, far outweighing the cost of doing the research.

Question 5

What legal boundaries must CI respect in different regions?

Accepted Answer

Competitive Intelligence (CI) must operate within legal and ethical limits in each region, avoiding illicit methods of gathering data. For example, in the US and Europe, CI professionals cannot misrepresent themselves to obtain information or steal trade secrets-such actions violate laws like trade secret protection and anti-hacking statutes. Privacy regulations (like GDPR in Europe) also set boundaries: any personal data collected about competitors' employees or customers needs a lawful basis or consent. Many countries explicitly outlaw industrial espionage tactics (bribery, covert surveillance, etc.), even if gathering public information is permitted. Antitrust or competition laws further restrict sharing certain competitive information across companies, so CI cannot cross into collusion. In short, CI efforts should stick to publicly available or ethically obtained data and respect privacy, with practitioners following professional codes of conduct to navigate different legal environments.

Libran Research & Consulting

What is Libran Research & Consulting?

Recognition

Services and Expertise